Yüklüyor......
New treatments/targets for primary biliary cholangitis
Primary biliary cholangitis (PBC) is an autoimmune, cholestatic, chronic liver disease that ultimately progresses towards cirrhosis and liver failure if untreated. While ursodeoxycholic acid has been established as standard of care for PBC in the last few decades, significant advances in second-line...
Kaydedildi:
| Yayımlandı: | JHEP Rep |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7001536/ https://ncbi.nlm.nih.gov/pubmed/32039371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2019.05.005 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|